In contrast, defects in the arginine biosynthetic pathway due to epigenetic silencing of argininosuccinate synthetase (ASS1) has been associated with poor prognosis in GBM, indicating that metabolic circuitries are subject to complex molecular and genetic regulations [26]. The gene discussed is ASS1; the disease is glioblastoma.